{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:20:41Z","timestamp":1697260841137},"reference-count":24,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T00:00:00Z","timestamp":1228953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Until now, it remains elusive which strategy \u2013 antithyroid drug withdrawal or increased radioiodine target doses \u2013 should be preferred to avoid the detrimental effect of antithyroid drugs in high\u2010 and low\u2010dose radioiodine therapy, respectively.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> We explored the effects of carbimazole on the 1\u2010year post\u2010radioiodine success and hypothyroidism rates by continuous dose\u2013effect models, whereas success was defined as elimination of hyperthyroidism. Euthyroidism rates with and without carbimazole were calculated by numerical integration of the area between success and hypothyroidism curves. Target dose amplification factors for equal chance of success with and without carbimazole were calculated using logistic regression.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Two\u00a0hundred and twenty\u2010eight patients were included in this study. Radioiodine target doses between 33 and 839\u00a0Gy were applied. Overall, the euthyroidism rates were 16\u00b75% and 64\u00b78%, while the hypothyroidism rates were 37\u00b76% and 14\u00b78% in Graves\u2019 disease and toxic nodular goitre, respectively. The success rate with simultaneous carbimazole (median dose 15\u00a0mg\u00a0day<jats:sup>\u22121<\/jats:sup>; range 2\u00b75\u201360\u00a0mg\u00a0day<jats:sup>\u22121<\/jats:sup>) was reduced over the entire target dose range in Graves\u2019 disease and toxic nodular goitre. The areas between curves for euthyroidism without and with simultaneous carbimazole were 127 and 43\u00a0Gy in Graves\u2019 disease and 178 and 128\u00a0Gy in toxic nodular goitre. The estimated radioiodine target dose amplification factor was 5\u00b75 for Graves\u2019 disease and 3\u00b70 for toxic nodular goitre.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Simultaneous carbimazole reduces the euthyroidism rate, the aim of low\u2010dose radioiodine therapy, over the entire target dose range in both Graves\u2019 disease and toxic nodular goitre. Therefore, antithyroid drug discontinuation should be preferred in low\u2010dose radioiodine therapy. Conversely, escalation of the target dose should be preferred in high\u2010dose radioiodine therapy.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2008.02061.x","type":"journal-article","created":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T21:12:11Z","timestamp":1229029931000},"page":"51-57","source":"Crossref","is-referenced-by-count":9,"title":["Different strategies to overcome the effect of carbimazole on high\u2010 and low\u2010dose radioiodine therapy: results from continuous dose\u2013effect models"],"prefix":"10.1111","volume":"39","author":[{"given":"M. A.","family":"Walter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Christ\u2010Crain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"M\u00fcller\u2010Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,11]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406163302407"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.4.1229"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0092-8"},{"key":"e_1_2_7_5_2","first-page":"1263","article-title":"Simultaneous treatment of toxic diffuse goiter with I\u2010131 and antithyroid drugs: a prospective study","volume":"20","author":"Steinbach JJ","year":"1979","journal-title":"J Nucl Med"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0226"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39114.670150.BE"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-38-451-536"},{"key":"e_1_2_7_9_2","first-page":"241","article-title":"One\u2010year follow\u2010up of Graves\u2019 disease treatment by four different protocols of radioiodine administration","volume":"42","author":"Calegaro JU","year":"2000","journal-title":"Panminerva Med"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-002-0831-4"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0801880"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc081426"},{"key":"e_1_2_7_13_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0038-1623926","article-title":"[Where does subclinical hypothyroidism start? Implications for the definition of the upper reference limit for thyroid stimulating hormone]","volume":"44","author":"Zophel K","year":"2005","journal-title":"Nuklearmedizin"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp010145"},{"key":"e_1_2_7_15_2","first-page":"33","article-title":"Radioiodine uptake and thyroid hormone levels on or off simultaneous carbimazole medication: a prospective paired comparison","volume":"44","author":"Walter MA","year":"2005","journal-title":"Nuklearmedizin"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2004.01349.x"},{"key":"e_1_2_7_17_2","first-page":"1632","article-title":"Optimized dose planning of radioiodine therapy of benign thyroidal diseases","volume":"34","author":"Bockisch A","year":"1993","journal-title":"J Nucl Med"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(60)90334-2"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI102194"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002590100621"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-002-0877-3"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020805"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-002-0910-6"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.1181"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-002-0785-6"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2008.02061.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2008.02061.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:07:22Z","timestamp":1697234842000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2008.02061.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,11]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1111\/j.1365-2362.2008.02061.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2008.02061.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,11]]}}}